OraSure Technologies, Inc.

NASDAQ:OSUR

Medical - Instruments & Supplies

Healthcare
$3.59 -3.47%

-$0.16 today

Market cap
$247.88M
Beta
1.01
P/E (TTM)
-4.0
EPS (TTM)
-$1.08
52W Low $2.08High $4.58

Volume 0.49M

Average 0.61M

OSUR Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

OraSure Technologies, Inc.NASDAQ: OSUR

Deferred Revenue · Q1 FY2026 · quarter ended Mar 2026

Deferred revenue falls 65.3% from a year ago

Deferred revenue stood at $872K at the end of Q1 FY2026, down 65.3% from a year earlier and down 42.6% from the prior quarter. Over 3 fiscal years it compounded at -12.6% a year.

Context

  • Deferred revenue amounted to 0.2% of total assets at the end of Q1 FY2026, down 0.3 pp from a year earlier.
  • Deferred revenue increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether deferred revenue keeps falling in the next quarterly balance sheet after a -65.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$872K-42.6% QoQ
Last fiscal yearDec 2025
$1.52M-48.7% YoY
Year agoMar 2025
$2.51M-65.3% since
Deferred Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-65.3%——
1 year-48.7%——
3-year CAGR-12.6%——
5-year CAGR——
10-year CAGR——

Deferred Revenue history

USD · from the balance sheet

Latest · FY2025
1.52M USD
Year-over-year change
-48.7%
4-year CAGR
-15.2%

Deferred Revenue vs competitors

How OSUR compares with its peers on the latest reported figures

  • Peers report in different currencies, so deferred revenue is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -65.3% is the lowest of 5, against a peer median of -10.3%.
  • Deferred revenue amounts to 0.2% of total assets for OSUR, versus a peer median of 0.6%.
OSUR Competitors
Deferred Revenue for OSUR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CATXPerspective Therapeutics, Inc.Mar 2026$26.6M USD——6.5%
PREPrenetics Global LimitedMar 2026$2.95M USD-52.4%-18.4%1.7%
NYXHNyxoah S.A.Mar 2026€1.12M EUR+205.5%—1.1%
OSUROraSure Technologies, Inc.Mar 2026$872K USD-65.3%-12.6%0.2%
STIMNeuronetics, Inc.Mar 2026$833K USD+6.1%-27.5%0.7%
PROFProfound Medical Corp.Mar 2026$465.53K USD-26.8%—0.6%
NAUTNautilus Biotechnology, Inc.Mar 2026$0 USD——0.0%
UTMDUtah Medical Products, Inc.Mar 2026$0 USD——0.0%
TARAProtara Therapeutics, Inc.Mar 2026$0 USD——0.0%
NTHINeonc Technologies Holdings, Inc.Mar 2026$0 USD——0.0%
Peer median (excluding OSUR) —-10.3%-23.0%0.6%

Competitors are the stored peer set for OSUR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents116.76M83.98M290.41M267.76M199.28M
Short-term Investments36.28M26.87M000
Net Receivables45.32M70.8M40.17M23.82M22.2M
Inventory53.14M95.7M47.61M34.2M31.06M
Other Current Assets39.87M41.57M2.23M3.49M4.15M
Total Current Assets299.31M325.19M386.46M333.22M261.91M
Property, Plant & Equipment (Net)84.98M71.11M58.27M58.69M51.32M
Goodwill40.28M35.1M35.7M40.33M43.36M
Intangible Assets14.34M11.69M1.21M17.44M19.05M
Long-term Investments17.01M0028.3M25.96M
Tax Assets000156K271K
Other Non-current Assets5.07M1.09M1.22M1.53M1.3M
Total Non-current Assets161.68M118.99M96.39M146.44M141.26M
Total Assets460.99M444.18M482.85M479.66M403.17M
Account Payables28.02M38.02M13.15M8.17M6.52M
Short-term Debt00000
Tax Payables2.23M1.52M1.25M1.34M0
Deferred Revenue2.94M2.27M1.56M2.96M1.52M
Other Current Liabilities4.75M5.52M3.98M5.22M21.18M
Total Current Liabilities68.06M69.06M39.54M33.48M39.8M
Long-term Debt00000
Deferred Tax Liabilities2.23M408K554K00
Deferred Revenue (Non-current)00000
Other Non-current Liabilities1.01M680K696K23.4M11.58M
Total Non-current Liabilities12.39M10.69M12.64M35.84M22.55M
Total Liabilities80.46M79.76M52.17M69.32M62.34M
Common Stock00000
Retained Earnings(120.45M)(137.59M)(83.93M)(103.43M)(172.16M)
Accumulated OCI(10.08M)(18.44M)(14.94M)(24.36M)(18.4M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity380.53M364.43M430.67M410.34M340.83M
Total Debt12.27M12.55M13.5M14.6M13.2M
Net Debt(104.49M)(71.43M)(276.9M)(253.16M)(186.08M)

OraSure Technologies, Inc.

NASDAQ:OSUR

Intrinsic Alpha fair value

Locked

Current Price

$3.59

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.